Jefferies resumed coverage on 10x Genomics with a new price target
$TXG
Biotechnology: Laboratory Analytical Instruments
Industrials
Jefferies resumed coverage of 10x Genomics with a rating of Hold and set a new price target of $24.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/13/2025 | $25.00 → $12.00 | Outperform → Market Perform | Leerink Partners |
| 9/3/2024 | $35.00 | Outperform | Leerink Partners |
| 7/22/2024 | $24.00 | Hold → Buy | Jefferies |
| 7/18/2024 | $40.00 → $20.00 | Overweight → Neutral | JP Morgan |
| 7/10/2024 | $55.00 → $25.00 | Buy → Hold | Deutsche Bank |
| 6/27/2024 | Outperform → Peer Perform | Wolfe Research | |
| 6/25/2024 | Buy → Neutral | Guggenheim | |
| 6/3/2024 | $24.00 | Hold | Jefferies |
8-K - 10x Genomics, Inc. (0001770787) (Filer)
144 - 10x Genomics, Inc. (0001770787) (Subject)
144 - 10x Genomics, Inc. (0001770787) (Subject)